198 related articles for article (PubMed ID: 17582606)
21. Regulatory T cells in a spectrum of HPV-induced cervical lesions: cervicitis, cervical intraepithelial neoplasia and squamous cell carcinoma.
Adurthi S; Krishna S; Mukherjee G; Bafna UD; Devi U; Jayshree RS
Am J Reprod Immunol; 2008 Jul; 60(1):55-65. PubMed ID: 18593438
[TBL] [Abstract][Full Text] [Related]
22. Human Papillomavirus Type 16 Disables the Increased Natural Killer Cells in Early Lesions of the Cervix.
Zhang J; Jin S; Li X; Liu L; Xi L; Wang F; Zhang S
J Immunol Res; 2019; 2019():9182979. PubMed ID: 31183395
[TBL] [Abstract][Full Text] [Related]
23. Immunohistochemical analysis of CD4+ and CD8+ T-cell subsets in high risk human papillomavirus-associated pre-malignant and malignant lesions of the uterine cervix.
Monnier-Benoit S; Mauny F; Riethmuller D; Guerrini JS; Căpîlna M; Félix S; Seillès E; Mougin C; Prétet JL
Gynecol Oncol; 2006 Jul; 102(1):22-31. PubMed ID: 16427684
[TBL] [Abstract][Full Text] [Related]
24. Impaired NK cells' activity and increased numbers of CD4 + CD25+ regulatory T cells in multidrug-resistant Mycobacterium tuberculosis patients.
Fan R; Xiang Y; Yang L; Liu Y; Chen P; Wang L; Feng W; Yin K; Fu M; Xu Y; Wu J
Tuberculosis (Edinb); 2016 May; 98():13-20. PubMed ID: 27156613
[TBL] [Abstract][Full Text] [Related]
25. Characterization of humoral immune responses against p16, p53, HPV16 E6 and HPV16 E7 in patients with HPV-associated cancers.
Reuschenbach M; Waterboer T; Wallin KL; Einenkel J; Dillner J; Hamsikova E; Eschenbach D; Zimmer H; Heilig B; Kopitz J; Pawlita M; Doeberitz Mv; Wentzensen N
Int J Cancer; 2008 Dec; 123(11):2626-31. PubMed ID: 18785210
[TBL] [Abstract][Full Text] [Related]
26. Immune activation in cervical neoplasia: cross-sectional association between plasma soluble interleukin 2 receptor levels and disease.
Hildesheim A; Schiffman MH; Tsukui T; Swanson CA; Lucci J; Scott DR; Glass AG; Rush BB; Lorincz AT; Corrigan A; Burk RD; Helgesen K; Houghten RA; Sherman ME; Kurman RJ; Berzofsky JA; Kramer TR
Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):807-13. PubMed ID: 9332763
[TBL] [Abstract][Full Text] [Related]
27. Polyclonal expansion of human CD4(+)CD25(+) regulatory T cells.
Hoffmann P; Eder R; Edinger M
Methods Mol Biol; 2011; 677():15-30. PubMed ID: 20941600
[TBL] [Abstract][Full Text] [Related]
28. Human papilloma virus specific T cells infiltrating cervical cancer and draining lymph nodes show remarkably frequent use of HLA-DQ and -DP as a restriction element.
Piersma SJ; Welters MJ; van der Hulst JM; Kloth JN; Kwappenberg KM; Trimbos BJ; Melief CJ; Hellebrekers BW; Fleuren GJ; Kenter GG; Offringa R; van der Burg SH
Int J Cancer; 2008 Feb; 122(3):486-94. PubMed ID: 17955486
[TBL] [Abstract][Full Text] [Related]
29. The detection of circulating human papillomavirus-specific T cells is associated with improved survival of patients with deeply infiltrating tumors.
Heusinkveld M; Welters MJ; van Poelgeest MI; van der Hulst JM; Melief CJ; Fleuren GJ; Kenter GG; van der Burg SH
Int J Cancer; 2011 Jan; 128(2):379-89. PubMed ID: 20473854
[TBL] [Abstract][Full Text] [Related]
30. [Correlation study of HPV-16 existential status with Th17/Treg cytokines].
Ding AP; Zhang Y; Wei H; Luo QS; Zhang SL
Zhonghua Yi Xue Za Zhi; 2013 Oct; 93(37):2957-60. PubMed ID: 24401583
[TBL] [Abstract][Full Text] [Related]
31. Langerhans cells from women with cervical precancerous lesions become functionally responsive against human papillomavirus after activation with stabilized Poly-I:C.
Da Silva DM; Woodham AW; Skeate JG; Rijkee LK; Taylor JR; Brand HE; Muderspach LI; Roman LD; Yessaian AA; Pham HQ; Matsuo K; Lin YG; McKee GM; Salazar AM; Kast WM
Clin Immunol; 2015 Dec; 161(2):197-208. PubMed ID: 26360252
[TBL] [Abstract][Full Text] [Related]
32. Increased expression of TIGIT and KLRG1 correlates with impaired CD56
Nie Y; Liu D; Yang W; Li Y; Zhang L; Cheng X; Chen R; Yuan B; Zhang G; Wang H
Virol J; 2022 Apr; 19(1):68. PubMed ID: 35413989
[TBL] [Abstract][Full Text] [Related]
33. IL-17 suppresses immune effector functions in human papillomavirus-associated epithelial hyperplasia.
Gosmann C; Mattarollo SR; Bridge JA; Frazer IH; Blumenthal A
J Immunol; 2014 Sep; 193(5):2248-57. PubMed ID: 25063870
[TBL] [Abstract][Full Text] [Related]
34. Generating HPV specific T helper cells for the treatment of HPV induced malignancies using TCR gene transfer.
Scholten KB; Turksma AW; Ruizendaal JJ; van den Hende M; van der Burg SH; Heemskerk MH; Meijer CJ; Hooijberg E
J Transl Med; 2011 Sep; 9():147. PubMed ID: 21892941
[TBL] [Abstract][Full Text] [Related]
35. Regulatory (FOXP3+) T cells as target for immune therapy of cervical intraepithelial neoplasia and cervical cancer.
Loddenkemper C; Hoffmann C; Stanke J; Nagorsen D; Baron U; Olek S; Huehn J; Ritz JP; Stein H; Kaufmann AM; Schneider A; Cichon G
Cancer Sci; 2009 Jun; 100(6):1112-7. PubMed ID: 19514119
[TBL] [Abstract][Full Text] [Related]
36. Regulatory T Cells but Not IL-10 Impair Cell-Mediated Immunity in Human Papillomavirus E7+ Hyperplastic Epithelium.
Bashaw AA; Zhou C; Yu M; Tolley L; Leggatt GR; Frazer IH; Chandra J
J Invest Dermatol; 2021 May; 141(5):1264-1273.e3. PubMed ID: 33129828
[TBL] [Abstract][Full Text] [Related]
37. HPV16 E7-Driven Epithelial Hyperplasia Promotes Impaired Antigen Presentation and Regulatory T-Cell Development.
Bashaw AA; Teoh SM; Tuong ZK; Leggatt GR; Frazer IH; Chandra J
J Invest Dermatol; 2019 Dec; 139(12):2467-2476.e3. PubMed ID: 31207230
[TBL] [Abstract][Full Text] [Related]
38. Glucocorticoid-induced tumor necrosis factor receptor expression in patients with cervical human papillomavirus infection.
Padovani CT; Bonin CM; Tozetti IA; Ferreira AM; Fernandes CE; Costa IP
Rev Soc Bras Med Trop; 2013; 46(3):288-92. PubMed ID: 23856878
[TBL] [Abstract][Full Text] [Related]
39. Vaccination during myeloid cell depletion by cancer chemotherapy fosters robust T cell responses.
Welters MJ; van der Sluis TC; van Meir H; Loof NM; van Ham VJ; van Duikeren S; Santegoets SJ; Arens R; de Kam ML; Cohen AF; van Poelgeest MI; Kenter GG; Kroep JR; Burggraaf J; Melief CJ; van der Burg SH
Sci Transl Med; 2016 Apr; 8(334):334ra52. PubMed ID: 27075626
[TBL] [Abstract][Full Text] [Related]
40. Tbet-positive regulatory T cells accumulate in oropharyngeal cancers with ongoing tumor-specific type 1 T cell responses.
Santegoets SJ; Duurland CL; Jordanova ES; van Ham JJ; Ehsan I; van Egmond SL; Welters MJP; van der Burg SH
J Immunother Cancer; 2019 Jan; 7(1):14. PubMed ID: 30658697
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
